Eastern Europe Western Europe Middle East Africa Central America South America Asia North America Australia
All India
who gmp
Product Description
Molnupiravir is the first oral, direct-acting antiviral shown to be highly effective at reducing nasopharyngeal SARS-CoV-2 infectious virus and viral RNA